SURGERY PARTNERS ($SGRY) posted quarterly earnings results on Monday, May 12th. The company reported earnings of $0.04 per share, missing estimates of $0.05 by $0.01. The company also reported revenue of $776,000,000, missing estimates of $792,633,289 by $-16,633,289.
You can see Quiver Quantitative's $SGRY stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
SURGERY PARTNERS Insider Trading Activity
SURGERY PARTNERS insiders have traded $SGRY stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $SGRY stock by insiders over the last 6 months:
- HARRISON R. BANE (National Group President) has made 0 purchases and 2 sales selling 60,360 shares for an estimated $1,541,643.
- JASON ERIC EVANS (Chief Executive Officer) sold 26,520 shares for an estimated $680,238
- DAVID T DOHERTY (Chief Financial Officer) has made 0 purchases and 2 sales selling 20,374 shares for an estimated $511,072.
- MARISSA BRITTENHAM (Chief Strategy Officer) has made 0 purchases and 2 sales selling 17,856 shares for an estimated $452,495.
- JENNIFER BALDOCK (Chief Admin & Dev Officer) has made 0 purchases and 3 sales selling 9,301 shares for an estimated $233,493.
- WILLIAM TRENTON WEBB (American Group President) has made 0 purchases and 3 sales selling 2,452 shares for an estimated $59,366.
- DANIELLE BURKHALTER (Chief Human Resources Officer) has made 0 purchases and 3 sales selling 1,481 shares for an estimated $35,981.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SURGERY PARTNERS Hedge Fund Activity
We have seen 100 institutional investors add shares of SURGERY PARTNERS stock to their portfolio, and 101 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 6,057,477 shares (+110.2%) to their portfolio in Q4 2024, for an estimated $128,236,788
- WELLINGTON MANAGEMENT GROUP LLP removed 3,919,912 shares (-39.8%) from their portfolio in Q4 2024, for an estimated $82,984,537
- FMR LLC removed 2,030,004 shares (-11.1%) from their portfolio in Q4 2024, for an estimated $42,975,184
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) removed 1,780,287 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $37,688,675
- BLACKROCK, INC. removed 1,577,510 shares (-20.4%) from their portfolio in Q1 2025, for an estimated $37,465,862
- KING STREET CAPITAL MANAGEMENT, L.P. added 1,350,000 shares (+93.1%) to their portfolio in Q4 2024, for an estimated $28,579,500
- POINT72 ASSET MANAGEMENT, L.P. added 1,208,639 shares (+224.7%) to their portfolio in Q4 2024, for an estimated $25,586,887
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SURGERY PARTNERS Analyst Ratings
Wall Street analysts have issued reports on $SGRY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cowen & Co. issued a "Buy" rating on 11/14/2024
- Jefferies issued a "Buy" rating on 11/13/2024
To track analyst ratings and price targets for SURGERY PARTNERS, check out Quiver Quantitative's $SGRY forecast page.
SURGERY PARTNERS Price Targets
Multiple analysts have issued price targets for $SGRY recently. We have seen 2 analysts offer price targets for $SGRY in the last 6 months, with a median target of $35.5.
Here are some recent targets:
- Brian Tanquilut from Jefferies set a target price of $40.0 on 11/13/2024
- Andrew Mok from Barclays set a target price of $31.0 on 11/13/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
